Services Design Development Scientific Advice Project Management QA – Quality Assurance Monitoring Clinical Performance Data Management/eTrials Biostatistics Medical Writing Expert Statement Expertise Pharmacokinetics BA/BE Interactions Oncological trials Ophthalmological trials Inhalatives Transdermal Therapeutic Systems Children Sexual Hormones Therapeutic Expertise Clinical Development Phase I Phase II / Proof of Concept Phase III in OTC Phase III Non-Interventional Magnetic Marker Monitoring Medical Devices Nutrition Studies Clinical Pharmacology Unit Location Plan Capacity Technical Monitoring Ophthalmology Gynaecology Intensive Assessment Unit Clean Room Area Archive About Us Goals and Visions Our Experts Science Quality Library Presentations Library Publications Locations Career News 22nd PKPD Expertentreffen in the heart of the Black Forest 3rd GBHI in Amsterdam: lively discussions and intensive exchange with authorities Meet us in Amsterdam: 3rd GBHI Conference starts soon (12 – 13 April 2018) Meet us in Munich: AGAH Annual Meeting 26 – 27 April 2018 Regorafenib: first in human as eye drops 3rd GBHI conference – all speakers confirmed Probanden The SocraTec Family SocraTec C&S SocraMetrics Cooperations
Clinical study Macular Sequential designs In vitro in vivo correlation DUS CDM Pharmacokintetics Biometrics Auditing Creativity CRO Steady state FIM Experience Patch Anaesthesiologist Allergy Pituitary Spacious archive Contraception Monitoring Biopharmaceutics Clinical Monitoring IMPD Rhine Main area Central surveillance system Paediatricians Audit IVIVC Female adolescents Protocol development Bioavailability Subcontractor qualification Sample size estimation Charcoal Pharmacology Database Ophthalmologist Life cycle management Ovulation inhibition Informed Consent Procedure Adrenocortical ICF Centralised procedure Phase IV Competence MDI Eye disease MMM Efficacy Bioequivalence Clinical development program COPD Scientific expertise EMA CRA DDI OTC Pharmacodynamic studies Referral system Elpro Phase I Unit Pilot study Immunogenicity GCP training Oncological patients Hypothalamic Phase IIa trials WinNonlin HRT Statistical services Patch adhesion Legal representative Uveitis Early phase Standardisation Edema SAS Phase I Source Data Verification Axis Data Validation Plan GLP Phase IIb trials First in human Drug Drug Interaction Data management Biopharmaceutical GCP ANVISA IEC Patients Dry eye Post authorisation Metered dose inhaler Pulse oximetry plethysmography HPA axis CDASH ADAM Ophthalmological trials NIS CDISC Statistical programming PASS Expert Sore throat Safety CRF Hormone replacement therapy Dry powder inhaler Oncologic network Phase III Healthy subjects Clinical trials DFI Good Clinical Practice Inhalatives Recruitment rates CDSIC Legal Information Drug Food Interaction SOP based US CFR 21 Part 11 Investigators brochure HTA Clinical pharmacology unit Slit lamp microscopy Data Management Plan Absorption windows MCID Project Management Degeneration SDV Asthma Endpoint Common cold Cardiovascular surveillance Network TTS Highly variable drugs Quality Management System Children Scientific advice Product development FDA AGAH Feasibility Sensitisation trials Postmenopausal women Non interventional Cough Lung Oncology Dermal irritation Quality Xerostomia Consultancy Absorption Thuringia Local tolerability Copyright Glaucoma Pragmatism Dose linearity Quality Assurance Ocular tolerability DPI Inspection SocraTec C&S Statistical Analysis Plan Protocol Phase II PAES Ophthalmology Intensive assessment station IB Authorities US FDA Patient recruitment Design development Training Standard operating procedure Pharmacokinetics Gynaecological trials Biosimilars Transdermal therapeutic system  
 
Menu

 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
All fine on front page